These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32802186)

  • 21. NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN/AKT/mTOR pathway.
    He W; Cheng F; Zheng B; Wang J; Zhao G; Yao Z; Zhang T
    Aging (Albany NY); 2021 May; 13(10):14015-14038. PubMed ID: 34030133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma.
    Jiang N; Niu G; Pan YH; Pan W; Zhang MF; Zhang CZ; Shen H
    EBioMedicine; 2020 Mar; 53():102692. PubMed ID: 32113161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance.
    Ho PY; Chueh SC; Chiou SH; Wang SM; Lin WC; Lee IL; Yang HY; Peng HC; Lai MK
    Urol Oncol; 2013 Oct; 31(7):1367-77. PubMed ID: 22417627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
    Wang Q; Ding H; He Y; Li X; Cheng Y; Xu Q; Yang Y; Liao G; Meng X; Huang C; Li J
    Cancer Lett; 2019 Mar; 444():9-19. PubMed ID: 30543814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.
    Long Q; Sun J; Lv J; Liang Y; Li H; Li X
    Exp Cell Res; 2020 Nov; 396(1):112286. PubMed ID: 32919955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MT1G induces lipid droplet accumulation through modulation of H3K14 trimethylation accelerating clear cell renal cell carcinoma progression.
    Wang S; Wang K; Yue D; Yang X; Pan X; Kong F; Zhao R; Bie Q; Tian D; Zhu S; He B; Bin Z
    Br J Cancer; 2024 Sep; 131(4):641-654. PubMed ID: 38906969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinoma.
    Matušan-Ilijaš K; Damante G; Fabbro D; Dorđević G; Hadžisejdić I; Grahovac M; Avirović M; Grahovac B; Jonjić N; Lučin K
    Clin Transl Oncol; 2013 Jan; 15(1):65-71. PubMed ID: 22855173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
    Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
    Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. YAP represses the TEAD-NF-κB complex and inhibits the growth of clear cell renal cell carcinoma.
    Li Z; Su P; Yu M; Zhang X; Xu Y; Jia T; Yang P; Zhang C; Sun Y; Li X; Yang H; Ding Y; Zhuang T; Guo H; Zhu J
    Sci Signal; 2024 Jul; 17(843):eadk0231. PubMed ID: 38954637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance.
    Feng C; Li Y; Li K; Lyu Y; Zhu W; Jiang H; Wen H
    J Exp Clin Cancer Res; 2021 Sep; 40(1):308. PubMed ID: 34593007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression.
    Zhang Q; Ni Y; Wang S; Agbana YL; Han Q; Liu W; Bai H; Yi Z; Yi X; Zhu Y; Sai B; Yang L; Shi Q; Kuang Y; Yang Z; Zhu Y
    Int J Med Sci; 2022; 19(1):47-64. PubMed ID: 34975298
    [No Abstract]   [Full Text] [Related]  

  • 33. Circ_RPL23A acts as a miR-1233 sponge to suppress the progression of clear cell renal cell carcinoma by promoting ACAT2.
    Cheng L; Cao H; Xu J; Xu M; He W; Zhang W; Dong L; Chen D
    J Bioenerg Biomembr; 2021 Aug; 53(4):415-428. PubMed ID: 34036483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFI16 promotes the progression of clear cell renal cell carcinoma through the IL6/PI3K/AKT axis.
    Lu K; Zhao Y; Li Y; Fu Z; Chen Y; Kong Y; Li G
    J Transl Med; 2024 Jun; 22(1):533. PubMed ID: 38831470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
    Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
    J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.
    Peri S; Devarajan K; Yang DH; Knudson AG; Balachandran S
    PLoS One; 2013; 8(10):e76746. PubMed ID: 24116146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PDZK1 confers sensitivity to sunitinib in clear cell renal cell carcinoma by suppressing the PDGFR-β pathway.
    Wang H; Zhang L; Liu H; Yang Y; Lu W; Cao X; Yang X; Qin Q; Song R; Feng D; Wang S; Bai T; He J
    Br J Cancer; 2024 Jul; 131(2):347-360. PubMed ID: 38822145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pan-cancer analysis, cell and animal experiments revealing TEAD4 as a tumor promoter in ccRCC.
    Li F; Feng Y; Jiang Q; Zhang J; Wu F; Li Q; Jing X; Wang X; Huang C
    Life Sci; 2022 Mar; 293():120327. PubMed ID: 35065165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
    Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q
    Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells.
    Allen A; Gau D; Francoeur P; Sturm J; Wang Y; Martin R; Maranchie J; Duensing A; Kaczorowski A; Duensing S; Wu L; Lotze MT; Koes D; Storkus WJ; Roy P
    J Biol Chem; 2020 Nov; 295(46):15636-15649. PubMed ID: 32883810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.